Tahamtan Mahshid, Kohlmeier Kristi Anne, Faatehi Mahdiyeh, Basiri Mohsen, Shabani Mohammad
Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Drug Design and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Brain Res Bull. 2021 Jun;171:25-34. doi: 10.1016/j.brainresbull.2021.03.007. Epub 2021 Mar 15.
The high mortality rate associated with acute kidney injury (AKI) is commonly due to progressive, inflammatory multiple organ dysfunction, which often involves neurological complications. The AKI-stimulated mechanisms leading to brain dysfunction are not well understood, which hinders development of new therapeutic avenues to minimize AKI-mediated neural effects. The hippocampal CA1 area is a particularly vulnerable region during AKI but the electrophysiological and inflammatory mechanisms involved in this vulnerability remain largely unknown. Here, we used immunohistochemistry to quantitatively investigate the number of astrocytes expressing glial fibrillary acidic protein (GFAP) as an indicator of inflammation, and whole cell patch clamp to evaluate electrophysiological changes in CA1 at different time points following induction of bilateral renal ischemia (BRI) in male Wistar rats. Further we evaluated the effectiveness of erythropoietin (EPO, 1000 U/kg i.p.) in mitigating BRI-associated changes. Plasma concentrations of blood urea nitrogen (BUN) were significantly enhanced at 24 h, 72 h and 1 week, and creatinine (Cr) was increased at 24 h after reperfusion, which were changes reduced by EPO. BRI led to an increase in CA1 GFAP-positive cells 24 h and 72 h, but not 1 week, after reperfusion, and EPO reversed this effect of BRI at 24 h. Additionally, BRI caused an increase in the peak amplitude and coefficient of variation of CA1 pyramidal neuronal action potentials, which were changes not seen in presence of EPO. When taken together, altered neuronal electrophysiological properties and astrogliosis could contribute to the neurological complications induced by AKI, and EPO offers hope as a potential neuroprotective agent.
急性肾损伤(AKI)相关的高死亡率通常归因于进行性、炎症性多器官功能障碍,这常常涉及神经并发症。导致脑功能障碍的AKI刺激机制尚未完全明确,这阻碍了开发新的治疗途径以最小化AKI介导的神经效应。海马CA1区在AKI期间是一个特别脆弱的区域,但参与这种脆弱性的电生理和炎症机制在很大程度上仍然未知。在此,我们使用免疫组织化学定量研究表达胶质纤维酸性蛋白(GFAP)的星形胶质细胞数量作为炎症指标,并采用全细胞膜片钳技术评估雄性Wistar大鼠双侧肾缺血(BRI)诱导后不同时间点CA1区的电生理变化。此外,我们评估了促红细胞生成素(EPO,1000 U/kg腹腔注射)减轻BRI相关变化的有效性。再灌注后24小时、72小时和1周时,血浆尿素氮(BUN)浓度显著升高,再灌注后24小时肌酐(Cr)升高,而EPO可减轻这些变化。BRI导致再灌注后24小时和72小时CA1区GFAP阳性细胞增加,但1周时未增加,EPO在24小时时逆转了BRI的这种作用。此外,BRI导致CA1锥体神经元动作电位的峰值幅度和变异系数增加,而在EPO存在的情况下未观察到这些变化。综合来看,神经元电生理特性的改变和星形胶质细胞增生可能导致AKI引起的神经并发症,而EPO有望成为一种潜在的神经保护剂。